| Oxalobacter| Oxalobacter Allison et al. 1985
Oxalate Metabolism: Oxalobacter formigenes is known for its ability to metabolize oxalate, a compound found in various foods. The bacterium can use oxalate as a carbon and energy source. Oxalate is a component of some kidney stones, and its metabolism by Oxalobacter formigenes may be relevant in the context of kidney stone formation.
Influence on Kidney Stone Formation: Some studies suggest that the presence of Oxalobacter formigenes in the gut may be associated with a lower risk of kidney stone formation. The bacterium's ability to break down oxalate in the gut may reduce the amount of oxalate available for absorption into the bloodstream and subsequently excreted in the urine.
Protection Against Hyperoxaluria: Hyperoxaluria is a condition characterized by elevated levels of oxalate in the urine, which can contribute to the formation of kidney stones. Oxalobacter formigenes may play a protective role by reducing oxalate absorption.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 1.9 | 1 | 2780 | 0 | 1147 | 243.3 | 100 | 461.2 | 0 | 480 | 0 %ile | 100 %ile | ||
biomesight | 37.85 | 0 | 70 | 10 | 560 | 0 | 1132 | 332.4 | 190 | 407.9 | 0 | 690 | 0 %ile | 91.1 %ile |
thorne | 75.86 | 1 | 1335 | 0 | 666 | 91.3 | 4 | 293.4 | 0 | 55 | 0 %ile | 100 %ile | ||
thryve | 27.08 | 0 | 25 | 1 | 3236 | 0 | 1020 | 284.4 | 161 | 375.3 | 0 | 560 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Lab Teletest | 0 | 500 | 0 | 0.05 |
Jason Hawrelak | 100 | 10000 | 0.01 | 1 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 46.667 % | 0.08 % | 0.091 % | 7.0 | 15 |
BiomeSight | 39.804 % | 0.032 % | 0.038 % | 1179.0 | 2962 |
BiomeSightRdp | 12.903 % | 0.038 % | 0.018 % | 4.0 | 31 |
CerbaLab | 66.667 % | 0.002 % | 0.003 % | 2.0 | 3 |
CosmosId | 6.25 % | 0.002 % | 0.001 % | 2.0 | 32 |
custom | 21.311 % | 0.028 % | 0.016 % | 13.0 | 61 |
es-xenogene | 75.862 % | 0.01 % | 0.013 % | 22.0 | 29 |
GanzimmunDiag | 100 % | 0.039 % | 0 % | 3.0 | 3 |
Medivere | 85.714 % | 0.019 % | 0.041 % | 6.0 | 7 |
SequentiaBiotech | 19.444 % | 0.017 % | 0.007 % | 7.0 | 36 |
Thorne | 61.765 % | 0.005 % | 0.018 % | 63.0 | 102 |
Thryve | 25.774 % | 0.028 % | 0.035 % | 358.0 | 1389 |
Tiny | 50 % | 0.001 % | % | 1.0 | 2 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.